Beijing BIOOCUS Biotech Ltd. specializes in the development of innovative diagnostic and therapeutic solutions for bladder carcinoma. Our flagship product, BladXtract, is a cutting-edge urine-based test that detects bladder carcinoma with high sensitivity and specificity, BladXtract is a non-invasive and easy-to-use diagnostic tool that provides accurate and reliable results, allowing for early detection of bladder carcinoma and monitoring of disease progression. The test is based on advanced technology and proprietary biomarkers, offering a significant improvement over traditional methods, In addition to diagnostics, Beijing BIOOCUS Biotech Ltd. is also dedicated to advancing the treatment of bladder carcinoma. Our research and development team is working on a novel immunotherapy approach that shows promising results in preclinical studies, With our commitment to scientific innovation and clinical excellence, Beijing BIOOCUS Biotech Ltd. is at the forefront of efforts to improve patient outcomes in bladder carcinoma. We are dedicated to bringing impactful solutions to the market and making a meaningful difference in the lives of patients and their families
Please feel free to give your inquiry in the form below We will reply you in 24 hours